OnKure Therapeutics, Inc.·4

Oct 2, 4:16 PM ET

Manke Isaac 4

4 · OnKure Therapeutics, Inc. · Filed Oct 2, 2025

Insider Transaction Report

Form 4
Period: 2025-09-30
Manke Isaac
Director
Transactions
  • Award

    Class A Common Stock

    2025-09-30+5,54515,325 total
Footnotes (1)
  • [F1]These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.

Documents

1 file
  • 4
    form4-10022025_081020.xmlPrimary